BRTX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
BRTX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
BioRestorative Therapies's yield on cost for the quarter that ended in Sep. 2024 was 0.00.
The historical rank and industry rank for BioRestorative Therapies's 5-Year Yield-on-Cost % or its related term are showing as below:
For the Biotechnology subindustry, BioRestorative Therapies's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, BioRestorative Therapies's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where BioRestorative Therapies's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of BioRestorative Therapies is calculated as
Yield-on-Cost | = | Dividend Yield % | * | (1 | + | Dividend Growth Rate)^5 |
BioRestorative Therapies (NAS:BRTX) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Thank you for viewing the detailed overview of BioRestorative Therapies's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.
Dale Broadrick | 10 percent owner | 3003 BRICK CHURCH PIKE, NASHVILLE TN 37207 |
Francisco Silva | director, 10 percent owner, officer: VP of Research and Development | STEM CELL ASSURANCE, INC., 555 HERITAGE DRIVE, JUPITER FL 33458 |
Lance Alstodt | director, 10 percent owner, officer: President, CEO, COB | BIORESTORATIVE THERAPIES, INC., 40 MARCUS DRIVE, SUITE 1, MELVILLE NY 11747 |
Robert Eugene Kristal | officer: Chief Financial Officer | 4719 COLE AVENUE, DALLAS TX 75205 |
Patrick F. Williams | director | C/O ZELTIQ AESTHETICS INC., 4698 WILLOW ROAD, SUITE 100, PLEASANTON CA 94588 |
David A Rosa | director | 10901 RED CIRCLE DRIVE, SUITE 150, MINNETONKA MN 55343 |
Nickolay V. Kukekov | director | 4524 WESTWAY AVE, DALLAS TX 75205 |
Mark Weinreb | director, 10 percent owner, officer: CEO and Chairman of the Board | STEM CELL ASSURANCE, INC., 555 HERITAGE DRIVE, JUPITER FL 33458 |
Paul Jude Tonna | director | 69 CHICHESTER ROAD, HUNTINGTON NY 11743 |
A. Jeffrey Radov | director | 8 WALWORTH AVENUE, SCARSDALE NY 10583 |
Robert Paccasassi | officer: VP, Quality and Compliance | C/O BIORESTORATIVE THERAPIES, INC., 40 MARCUS DRIVE, SUITE 1, MELVILLE NY 11747 |
Robert B Catell | director | 62 OSBORNE ROAD, GARDEN CITY NY 11530 |
Adam D. Bergstein | officer: SVP, Planning and Business Dev | 167 HAZEL AVENUE, GLENCOE IL 60022 |
John M Desmarais | director | 230 PARK AVENUE, NEW YORK NY 10169 |
Westbury Trust | 10 percent owner | VICTORIA HALL, 11 VICTORIA STREET, P.O. BOX HM 1065, HAMILTON D0 00000 |
From GuruFocus
By Marketwired • 06-17-2024
By Marketwired • 04-16-2024
By Marketwired • 10-03-2024
By Marketwired • 05-25-2024
By Marketwired • 04-30-2024
By ACCESSWIRE • 08-30-2023
By Marketwired • 11-06-2024
By Marketwired • 07-23-2024
By Marketwired • 05-14-2024
By Marketwired • 08-13-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.